Tight bands on legs may boost workout benefits for lung disease patients
NCT ID NCT07668921
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests whether using a blood flow restriction (BFR) device during exercise can increase muscle fatigue in people with COPD, potentially making rehab more effective. Forty participants will do one session of resistance or cycling exercise with and without BFR. The goal is to see if BFR helps build muscle while reducing breathing strain.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Blood flow restriction device
- What this could lead to
- If it works, this could point toward a more effective exercise program for people with COPD, helping them get stronger with less strain on their breathing.
- What could go wrong
- This is a very early, small study (40 people) looking only at immediate effects after a single session. It does not test long-term benefits or safety, and results may not apply to all COPD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Nov 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Negative pregnancy test and use of an acceptable contraceptive method throughout the study duration for women of childbearing potential * Established COPD defined as obstructive ventilatory defect (FEV1/FVC \< 0.70 or below the 5th percentile) * Resting lung hyperinflation defined as functional residual capacity \> 2.5 z-scores according to the Global Lung Function Initiative (GLI) * Clinical stability of COPD for at least 3 months, with no recent exacerbation requiring treatment modification * Covered by a national health insurance system * Able and willing to provide written informed consent Non-inclusion Criteria: * Presence of a medical device incompatible with magnetic stimulation * Inability to perform an exercise test on a cycle ergometer * Any usual contraindication to exercise testing, including: * Recent myocardial infarction (3-5 days) * Unstable coronary insufficiency * Severe stenotic valvular disease * Uncontrolled arrhythmia with hemodynamic instability * Recent unexplained syncope * Uncontrolled heart failure * Uncontrolled arterial hypertension (systolic blood pressure ≥200 mmHg and/or diastolic blood pressure ≥110 mmHg at rest) * Acute thromboembolic disease and/or pulmonary edema * Conditions contraindicating the use of blood flow restriction (BFR), including: * Coagulation disorder * Peripheral neuropathy * Uncontrolled hypertension (\>160/100 mmHg) * Peripheral arterial disease * History of venous thrombosis * Intensive care unit stay within the last 3 months * Participation in another study during an exclusion period * Inability to be contacted in case of emergency * Individuals covered under Articles L1121-5 to L1121-8 of the French Public Health Code (protected populations, including pregnant or breastfeeding women, prisoners, minors, individuals under legal protection, psychiatric inpatients, etc.) * Staff members with a hierarchical relationship with the principal investigator
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Blood flow restriction training (BFRT) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CReSI - Laboratoire HP2
La Tronche, Auvergne-Rhône-Alpes, 38700, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a chatbot be a friend to your mind? AI takes on student stress
- Can a digital parenting program empower latino families?
- One bike ride, big appetite shift? exercise may rewire food cravings in teens
- Library-Based app aims to ease teen anxiety
- New study aims to find best breathing support for COPD patients during lung surgery
- Can a 13-minute daily chat with a colleague reduce burnout? new study aims to find out.